Gabriele Sorce

ORCID: 0000-0003-2436-2412
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Bladder and Urothelial Cancer Treatments
  • Renal cell carcinoma treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Urological Disorders and Treatments
  • Urinary and Genital Oncology Studies
  • Urologic and reproductive health conditions
  • Surgical Simulation and Training
  • MRI in cancer diagnosis
  • Renal and Vascular Pathologies
  • Radiopharmaceutical Chemistry and Applications
  • Renal and related cancers
  • Colorectal Cancer Surgical Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Pelvic floor disorders treatments
  • Health Systems, Economic Evaluations, Quality of Life
  • Genital Health and Disease
  • Cancer, Lipids, and Metabolism
  • Urinary Bladder and Prostate Research
  • Radiation Dose and Imaging
  • Organ Donation and Transplantation
  • Statistical Methods in Clinical Trials
  • Multiple and Secondary Primary Cancers
  • Ureteral procedures and complications

Istituti di Ricovero e Cura a Carattere Scientifico
2021-2025

Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
2021-2025

ORSI Academy
2023-2025

Azienda Ospedaliera Universitaria Policlinico "G. Martino"
2024-2025

Onze Lieve Vrouwziekenhuis Hospital
2023-2024

IRCCS Ospedale San Raffaele
2020-2024

Vita-Salute San Raffaele University
2020-2024

Université de Montréal
2021-2023

McGill University Health Centre
2023

GTx (United States)
2022

We aimed to compare the outcomes of Robot-assisted sacrocolpopexy (RASC) performed using novel HUGOTM Robot-Assisted Surgery (RAS) System with Da Vinci® Xi surgical system.Data from 38 women undergoing RASC for a ≥ 2-grade pelvic organ prolapse were collected (2021-2023).Overall, 23 (60.5%) and 15 (39.5%) procedures DaVinci® RAS system, respectively. The median total operative time was 123 (IQR:106.5-140.5) minutes versus 120 (IQR:120-146) cases (p = 0.5). No conversion open/laparoscopic...

10.1002/rcs.2587 article EN International Journal of Medical Robotics and Computer Assisted Surgery 2023-10-20

Guidelines suggest less favorable cancer control outcomes for local tumor destruction in T1a renal cell carcinoma patients with size 3.1-4 cm. We compared cancer-specific mortality between cryoablation vs heat-based thermal ablation cm, as well ≤3 cm.Within the Surveillance, Epidemiology, and End Results database (2004-2018), we identified clinical stage treated or ablation. After up to 2:1 ratio propensity score matching ablation, addressed relying on competing risks regression models,...

10.1097/ju.0000000000002984 article EN The Journal of Urology 2022-11-28

To assess the relationship between volume of index lesion (IL) measured at multiparametric magnetic resonance imaging (mpMRI; MRIvol) and radical prostatectomy (RPvol), stratifying it according to Prostate Imaging-Reporting Data System (PI-RADS) score.We identified 332 men with a positive mpMRI (single PI-RADS ≥3) who underwent systematic plus targeted biopsy subsequent RP two tertiary referral centres 2013 2018. All mpMRIs were reviewed by experienced radiologists using scores. The study...

10.1111/bju.15498 article EN BJU International 2021-05-26

Background: Female sex in patients treated by radical cystectomy (RC) is associated with more advanced stage and worse survival. However, studies supporting these findings mostly or exclusively relied on urothelial carcinoma of the urinary bladder (UCUB) did not address non-urothelial variant-histology cancer (VH BCa). We hypothesized that female a survival VH BCa, similarly to UCUB. Materials Methods: Within SEER database (2004–2016), we identified aged ≥18 years, histologically confirmed...

10.3390/jcm12051776 article EN Journal of Clinical Medicine 2023-02-23

This study aimed to test for temporal trends of in-hospital venous thromboembolism (VTE) and pulmonary embolism (PE) after major urologic cancer surgery (MUCS).In the Nationwide Inpatient Sample (NIS) database (2010-2019), this identified non-metastatic radical cystectomy (RC), prostatectomy (RP), nephrectomy (RN), partial (PN) patients. Temporal VTE PE multivariable logistic regression analyses (MLR) addressing or PE, mortality with were performed.Of 196,915 patients, 1180 (1.0%) exhibited...

10.1245/s10434-023-14246-0 article EN cc-by Annals of Surgical Oncology 2023-09-18

Background: In February 2021 Medtronic® (Minneapolis, MN) launched the HUGOTM Robotic Assisted Surgery (RAS) System in global market. The aim of current study is to describe first cases series and optimal setup robot-assisted pyeloplasty procedure, performed with RAS system a tertiary referral robotic center. Methods: Data from consecutive patients who underwent at OLV Hospital (Aalst, Belgium) were recorded. Baseline characteristics, perioperative surgical outcomes collected. Results:...

10.1089/end.2023.0598 article EN Journal of Endourology 2024-01-25

Randomized clinical trials demonstrated improved overall survival in chemotherapy exposed metastatic prostate cancer patients. However, real-world data validating this effect with large scale epidemiological sets are scarce and might not agree trials. We tested hypothesis.We identified de novo patients within the Surveillance, Epidemiology, End Results (SEER) database (2014-2015). Kaplan-Meier plots Cox regression models for differences between chemotherapy-exposed vs chemotherapy-naïve All...

10.3389/fonc.2021.778858 article EN cc-by Frontiers in Oncology 2021-11-23
Coming Soon ...